APO-TOFACITINIB
As listed in the register: APO-TOFACITINIB
10 mg · tablet
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Tofacitinib (Tofacitinib Citrate)
- Made by
- Apotex Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Bulgaria1 matching products
European UnionNo exact match for this strength and form
Spain2 matching products
Netherlands4 matching products
SwitzerlandNo exact match for this strength and form
Details
| Made by | Apotex Inc |
|---|---|
| Active substance | Tofacitinib (Tofacitinib Citrate) |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 10 mg |
| Form | tablet |
| Classification | L04AF01 · Cancer treatments and immune-system medicines |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Approved |
| Marketed | No — authorised but not currently marketed, according to the register |
| DIN | 02538261 |
| DPD drug code | 102701 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- tablet2 products
- 5 mg
- 10 mg
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.